GB201905878D0 - Retentive formulation - Google Patents

Retentive formulation

Info

Publication number
GB201905878D0
GB201905878D0 GBGB1905878.3A GB201905878A GB201905878D0 GB 201905878 D0 GB201905878 D0 GB 201905878D0 GB 201905878 A GB201905878 A GB 201905878A GB 201905878 D0 GB201905878 D0 GB 201905878D0
Authority
GB
United Kingdom
Prior art keywords
retentive formulation
retentive
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1905878.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Drug Delivery International Ltd
Original Assignee
Drug Delivery International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery International Ltd filed Critical Drug Delivery International Ltd
Priority to GBGB1905878.3A priority Critical patent/GB201905878D0/en
Publication of GB201905878D0 publication Critical patent/GB201905878D0/en
Ceased legal-status Critical Current

Links

GBGB1905878.3A 2019-04-26 2019-04-26 Retentive formulation Ceased GB201905878D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1905878.3A GB201905878D0 (en) 2019-04-26 2019-04-26 Retentive formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1905878.3A GB201905878D0 (en) 2019-04-26 2019-04-26 Retentive formulation

Publications (1)

Publication Number Publication Date
GB201905878D0 true GB201905878D0 (en) 2019-06-12

Family

ID=66809141

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1905878.3A Ceased GB201905878D0 (en) 2019-04-26 2019-04-26 Retentive formulation

Country Status (1)

Country Link
GB (1) GB201905878D0 (en)

Similar Documents

Publication Publication Date Title
GB2592822B (en) Therapeutic compositions
GB201807942D0 (en) Pharmaceutical formulation
EP4125815A4 (en) Therapeutic compositions
ZA202006570B (en) Pharmaceutical formulations
IL285674A (en) Pharmaceutical formulations
ZA202102871B (en) Pharmaceutical formulation
IL278927A (en) Pharmaceutical formulation
IL290894A (en) Pharmaceutical formulation
GB201904338D0 (en) Fluorouracil-containing formulations
IL284688A (en) Formulation
PT4045038T (en) New formulations
IL290356A (en) Larazotide formulations
IL284691A (en) Formulations
GB201913232D0 (en) Aerosolisable formulation
GB201906473D0 (en) Pharmaceutical formulation
SG11202010792TA (en) Improved pharmaceutical formulations
GB201905878D0 (en) Retentive formulation
GB202115200D0 (en) Retentive formulation
GB2587402B (en) Formulation
GB201906242D0 (en) Aerosolisable formulation
GB201900658D0 (en) Formulation
GB201911063D0 (en) Formulations
GB201905105D0 (en) Formulations
SG11202011823SA (en) Activator-nucleator formulations
GB201909868D0 (en) Therapeutic compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)